117 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
Ended
March 31,
(Unaudited)
Revenues, net
Cost of product revenues
Gross profit
Operating expenses:
Research and development
Selling and marketing
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
)
December 31,
Revenues, net
Cost of product revenues
Gross profit
Operating expenses:
Research and development
Selling and marketing
General
8-K
EX-99.1
28e60xhz x7
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K/A
EX-10.1
sbdmtyh8ry0c1qdx9v4g
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
n335 0mzx89sd9w
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
424B4
jovt301sgfaz
24 May 23
Prospectus supplement with pricing info
4:05pm
8-K
EX-99.1
3oj7rwzgfzqo wqoyxl
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm